• Title/Summary/Keyword: treatments for PID

Search Result 3, Processing Time 0.015 seconds

A Study on Pelvic Inflammatory Disease (골반 염증성 질환에 관한 고찰)

  • Lee, Bo-Ra;Yoo, Dong-Yul
    • Journal of Haehwa Medicine
    • /
    • v.17 no.2
    • /
    • pp.155-160
    • /
    • 2008
  • Pelvic inflammatory disease (PID) is a general term that refers to infection of the internal reproductive organs such as the female uterus, fallopian tubes, and ovaries. PID is caused by germs that invade the genital organs, causing the acute inflammatory reaction, and chronic PID is to have a recurrence of PID because of the lack of effective treatment of acute PID. Symptoms of PID include pelvic pain, fever, leukorrhea, infertility, and fatigue. Treatments for PID can be improved by combining herb medicine therapy, intestinal irrigation, or the therapy that put herb medicine on the abdominal region with antibiotics, or analgesic drugs.

  • PDF

Comparison of Fentanyl-Based Rapid Onset Opioids for the Relief of Breakthrough Cancer Pain: Drug Price Based on Effect Size

  • Seongchul Kim;Hayoun Jung;Jina Park;Jinsol Baek;Yeojin Yun;Junghwa Hong;Eunyoung Kim
    • Korean Journal of Clinical Pharmacy
    • /
    • v.33 no.1
    • /
    • pp.43-50
    • /
    • 2023
  • Background and Objective: With the advancement of cancer treatments and increased life expectancy, managing breakthrough cancer pain (BTcP) is essential to improve the quality of life for cancer patients. This study aimed to compare the major rapid onset opioids in Korea based on their characteristics and costs to determine the best option for each patient. Methods: Based on sales information from IQVIA-MIDAS, sublingual fentanyl tablet (SLF), fentanyl buccal tablet (FBT), and oral transmucosal fentanyl citrate (OTFC) were selected as the top three drugs for the treatment of BTcP in Korea, considering them the most comparable drugs. The cost and cost-pain relief ratio of the drugs for short-term (1 month) and long-term (1 year) treatment were compared and the ease of administration based on various factors, including pharmacokinetics, onset of action, and administration procedures were evaluated. Results: SLF was evaluated as the best overall in terms of rapid onset of action, ease of administration, and drug cost and also had the highest market share. SLF had the lowest cost pain relief ratio for both the initial and supplemental treatment for the 1-month pain intensity difference 15 (PID15) ratio. However, for the 1-month PID30 ratio, SLF was not superior to OTFC or FBT. The longer the breakthrough cancer pain duration, the more cost-effective the other rapid onset opioids. Conclusion: The rapid onset opioids that fit the patient's breakthrough cancer pain pattern have the best cost-effectiveness.

A Clinical Report on Two Patients with Chronic Pelvic Inflammatory Disease (만성 골반염 환자 2례의 임상증례보고)

  • Lee, Eun-Kyu;Kim, Soo-Hyeon;Jeon, Yeong-Seon;Choi, Yoo-Jin;Park, Kyeong-Mi;Yang, Seung-Jeong;Park, Chan-Wook;Cho, Seong-Hee
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.31 no.3
    • /
    • pp.109-120
    • /
    • 2018
  • Objectives: The purpose of this study is to report the effect of Korean medicine treatments on a chronic pelvic inflammatory disease (CPID). Methods: We treated 2 cases of chronic pelvic inflammatory disease patients with Korean herbal medicine, acupuncture and moxibustion. One patient is a 50 years old woman, who suffered from uterine bleeding, lower abdominal pain, right pelvic pain. She was treated with Gwichuligyeong-tang-gami and Samul-tang-gami. Other patient is a 40 year old woman, who appealed for pain such as pelvic pain, lower abdominal pain, urinary frequancy, dysuria. She was treated with Cheongpochugeo-tang. Both patients are taken acupuncture at Junggeuk (CV3), Gwanwon (CV4), Chagung (CA111), Sameumgyo (SP6), Eumneungcheon (SP9) and moxified at Gwanwon (CV4). Results: After treatments, their symptoms were remarkably improved. Conclusions: This study suggests that Korean medicine treatments have significant effect on reducing symptoms of chronic pelvic inflammatory disease.